Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Response of GSK2190915 in Exercise-Induced Bronchoconstriction
NCT00812929Phase 2Completed
- Sponsor
- GSK
- Start
- Dec 2008
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fiboflapon in asthma, Exercise-induced bronchoconstriction (EIB), sponsored by GSK. Started Dec 2008; status: completed.
02
Drugs
fiboflapon
03
Conditions
asthmaExercise-induced bronchoconstriction (EIB)
Beyond the preview
Go deeper on NCT00812929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00812929.